{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:13:57Z","timestamp":1779236037916,"version":"3.51.4"},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.4155\/bio-2023-0196","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T11:34:55Z","timestamp":1703072095000},"page":"5-17","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["A Singlicate Immunogenicity Method to Detect Anti-Polyethylene Glycol Antibodies: Pre- and Post-Dose of PEGylated Therapies"],"prefix":"10.1080","volume":"16","author":[{"given":"Issa","family":"Jyamubandi","sequence":"first","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanya","family":"Aamir","sequence":"additional","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Kaur","sequence":"additional","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alen","family":"Sylvester","sequence":"additional","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hughes","sequence":"additional","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Li","sequence":"additional","affiliation":[{"name":"Resolian, Newmarket Road, Fordham, Ely, CB7 5WW, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Biopharma PEG . FDA approv. PEGylated drugs by 2023 (2023). www.biochempeg.com\/article\/58.html"},{"key":"e_1_3_4_4_1","first-page":"5","article-title":"Molecular dynamics simulations on aqueous two-phase systems \u2013 single PEG-molecules in solution","author":"Oelmeier SA","year":"2012","unstructured":"Oelmeier SA , Dismer F , Hubbuch J . Molecular dynamics simulations on aqueous two-phase systems \u2013 single PEG-molecules in solution. BMC Biophys. 5\u201314 (2012).","journal-title":"BMC Biophys."},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","unstructured":"Shi L Zhang J Zhao M et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. 10748\u201310764 (2021).","DOI":"10.1039\/D1NR02065J"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1067-7"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.879988"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4500"},{"key":"e_1_3_4_9_1","first-page":"71","article-title":"Withdrawal of its European marketing authorisation is welcome","volume":"26","author":"Prescrire P","year":"2017","unstructured":"Prescrire P . Withdrawal of its European marketing authorisation is welcome. Prescrire Int. 26, 71 (2017).","journal-title":"Prescrire Int."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.42"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.07.024"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2021.715844"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1961-x"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(10)60309-1"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000233512"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.6b03109"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.6b03437"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.12.022"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-020-00369-y"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.05.010"},{"key":"e_1_3_4_21_1","volume-title":"Immunogenicity Testing of Therapeutic Protein Products \u2013 Developing and Validating Assays for Anti-Drug Antibody Detection Guidance for Industry.","author":"US FDA","year":"2019","unstructured":"US FDA . Immunogenicity Testing of Therapeutic Protein Products \u2013 Developing and Validating Assays for Anti-Drug Antibody Detection Guidance for Industry. Spring, MD Silver Spring, MD, USA (2019)."},{"key":"e_1_3_4_22_1","volume-title":"Guideline on Immunogenicity Assessment of Therapeutic Proteins.","author":"European Medicines Agency","year":"2017","unstructured":"European Medicines Agency . Guideline on Immunogenicity Assessment of Therapeutic Proteins. The Medicines Agency, The Netherlands, Netherlands (2017)."}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio-2023-0196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:08:20Z","timestamp":1715958500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio-2023-0196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.4155\/bio-2023-0196"],"URL":"https:\/\/doi.org\/10.4155\/bio-2023-0196","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}